The Chemours (CC) Company announced that its Board of Directors has appointed Independent Director Mary Cranston as Chair of the Board and Alister Cowan to the role of Lead Independent Director, effective September 2, 2025. These appointments follow the departure of Dawn Farrell, who has accepted a position with the Canadian government as the Chief Executive Officer of the newly created Major Projects Office under the Building Canada Act.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC:
- Chemours Chair Dawn Farrell Resigns for New Role
- Chemours, SRF Limited announce strategic agreements in India
- Chemours Company Positioned for Growth with Samsung Endorsement and 2PIC Commercialization
- Chemours Company Reports Q2 2025 Financial Results
- Chemours Company Reports Strong Q2 Amid Challenges